To examine whether the liposome complex XA5508 has tumor-targeting properties, we injected mice with subcutaneous tumors with DiR-labeled XA5508, Lip-empty, and anti-PD-L1 Nb via the tail vein. Here, CD274 is linked to neoplasm.